Cargando…

Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia

Relationships between gut microbiota and various disease pathogeneses have been investigated, but those between the pathogeneses of mental illnesses, including schizophrenia, and gut microbiota have only recently attracted attention. We observed a change in the gut microbiota of a patient with schiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanayama, Misako, Hayashida, Maiko, Hashioka, Sadayuki, Miyaoka, Tsuyoshi, Inagaki, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413405/ https://www.ncbi.nlm.nih.gov/pubmed/30937205 http://dx.doi.org/10.1155/2019/4576842

Ejemplares similares

Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy
por: Kanayama, Misako, et al.
Publicado: (2018)

The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms
por: Hashioka, Sadayuki, et al.
Publicado: (2019)

Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat
por: Limoa, Erlyn, et al.
Publicado: (2016)

PM375. Electroconvulsive shock ameliorated the schizophrenia-like behavior and attenuated the glial activation in the hippocampus of Gunn Rat
por: Abdul Aziz, Erlyn Limoa Ilhamuddin, et al.
Publicado: (2016)

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report
por: Izuhara, Muneto, et al.
Publicado: (2018)

Parvalbumin-positive GABAergic interneurons deficit in the hippocampus in Gunn rats: A possible hyperbilirubinemia-induced animal model of schizophrenia
por: Hayashida, Maiko, et al.
Publicado: (2019)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

Implications of Systemic Inflammation and Periodontitis for Major Depression
por: Hashioka, Sadayuki, et al.
Publicado: (2018)

Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report
por: Otsuki, Koji, et al.
Publicado: (2021)

Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)
por: Hayashida, Maiko, et al.
Publicado: (2016)

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2017)

Contribution of “Genuine Microglia” to Alzheimer's Disease Pathology
por: Hashioka, Sadayuki, et al.
Publicado: (2022)

Magnetic Resonance Spectroscopy in the Ventral Tegmental Area Distinguishes Responders to Suvorexant Prior to Treatment: A 4-Week Prospective Cohort Study
por: Izuhara, Muneto, et al.
Publicado: (2021)

PS147. Gunn rats show depression-like behavior and microglial activation in the hippocampus
por: Arauchi, Ryosuke, et al.
Publicado: (2016)

Do Alzheimer's Disease Risk Gene Products Actually Act in Microglia?
por: Hashioka, Sadayuki, et al.
Publicado: (2020)

Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test
por: Arauchi, Ryosuke, et al.
Publicado: (2018)

PT596. The comparison with galantamine and donepezil on Alzheimer’s Disease patients and its relationship with cerebral blood flow
por: Wake, Rei, et al.
Publicado: (2016)

PM351. Efficacy and Safety of Sansoninto for Insomnia in Child and Adolescent Patients: An Open-Label Study
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2016)

Electroconvulsive therapy (ECT) and schizophrenia
por: Masin, Rhys, et al.
Publicado: (2021)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2015)

Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia
por: Zhu, Cuizhen, et al.
Publicado: (2021)

A decreased abundance of clostridia characterizes the gut microbiota in eosinophilic esophagitis
por: Kashyap, Purna C., et al.
Publicado: (2019)

Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat
por: Furuya, Motohide, et al.
Publicado: (2013)

Clostridium butyricum affects nutrition and immunology by modulating gut microbiota
por: YAMAMOTO, Masateru, et al.
Publicado: (2021)

Use of electroconvulsive therapy in adolescents with schizophrenia in China
por: Wang, Shuai, et al.
Publicado: (2018)

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2017)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

Effects of modified electroconvulsive therapy on the electroencephalogram of schizophrenia patients
por: Zhao, Ling, et al.
Publicado: (2016)

May Salivary Alpha-Amylase Level Be a Useful Tool for Assessment of the Severity of Schizophrenia and Evaluation of Therapy? A Case Report
por: Ieda, Masa, et al.
Publicado: (2012)

Epinephrine levels decrease in responders after electroconvulsive therapy
por: Pollak, Christoph, et al.
Publicado: (2021)

Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan
por: Hsieh, Yung-Yu, et al.
Publicado: (2018)

Electroconvulsive Therapy for Agitation in Schizophrenia: Metaanalysis of Randomized Controlled Trials
por: UNGVARI, Gabor S., et al.
Publicado: (2017)

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia
por: Khouadja, S., et al.
Publicado: (2021)

Predictors of cognitive changes in patients with schizophrenia undergoing electroconvulsive therapy
por: Rajagopalan, Arvind, et al.
Publicado: (2023)

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease
por: Hashioka, Sadayuki, et al.
Publicado: (2021)

Colonization Resistance of the Gut Microbiota against Clostridium difficile
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2015)

Diversity and Prevalence of Clostridium innocuum in the Human Gut Microbiota
por: Bhattacharjee, Disha, et al.
Publicado: (2022)

Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
por: Oñate, Florian Plaza, et al.
Publicado: (2023)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
por: Peitl, Vjekoslav, et al.
Publicado: (2023)

Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia
por: Garg, Rohit, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tkgnaeni861kt0d6uv1ehld994